Výsledky vyhledávání - "Tsutomu Hiromasa"

Akademický článek

Optimal treatment targets for lupus nephritis using per-protocol repeat kidney biopsy findings at 2 years and clinical data up to 5 years: a single-center observational study

Autor: Hidetoshi Kagawa, Ryutaro Yamanaka, Ai Matsubara, Tatsuyuki Inoue, Reika Hayashi, Natsuki Kubota, Tsutomu Hiromasa

Publikováno v: Therapeutic Advances in Chronic Disease, Vol 15 (2024)

Background: The criteria for remission in both clinical and pathological contexts for lupus nephritis (LN) remain controversial. Objectives: To identify optimal short-term goals (remission criteria) for LN predicting long-term success at 5 years, usi

Externí odkaz: https://doaj.org/article/6df20133df764673b3ca7c1f1c6987a6

Zobrazit plný text záznamu

Autor: Ai Matsubara, Yoko Tsunashima, Hidetoshi Kagawa, Tsutomu Hiromasa

Publikováno v: Internal Medicine. 62:667-669

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda9f617a526ce314333456c794a5d76
https://doi.org/10.2169/internalmedicine.9785-22

Zobrazit plný text záznamu

The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis

Autor: Ryutaro Yamanaka, Hidetoshi Kagawa, Ken-Ei Sada, Reika Hayashi, Tatsuyuki Inoue, Yoko Tsunashima, Tsutomu Hiromasa

Publikováno v: Clinical and Experimental Nephrology. 22:1371-1378

Despite the high efficacy of mycophenolate mofetil (MMF)/tacrolimus-based multitarget treatment, risks of infections are a matter of concern. In the present study, we clarified the potential of multitarget therapy using mizoribine opposed to MMF. A t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c84704f2e1a536f4bf655e05eaa4b726
https://doi.org/10.1007/s10157-018-1597-8

Zobrazit plný text záznamu

Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis

Autor: Ken-Ei Sada, Takayuki Hara, Tsutomu Hiromasa, Hirofumi Makino, Hidetoshi Kagawa, Ryutaro Yamanaka, Ayako Takaki

Publikováno v: Clinical and experimental nephrology. 16(5)

Conventional cyclophosphamide-based treatment regimens for lupus nephritis (LN) are still not considered to be optimal. The aim of this study was to evaluate the efficacy and safety of mizoribine, tacrolimus, and corticosteroid combination therapy fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e41781b9d105207960b0cc84e966f4d
https://pubmed.ncbi.nlm.nih.gov/22492013

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání